Goldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...

As per Sebi's T+1 settlement cycle, investors must buy a company's shares at least one trading day before the record date to ensure the sha...

We are in uncertain and volatile times. Does that mean investors should just sit out the downturn? While that is an option, the better opti...

Investors must hold shares in their demat accounts on the respective record dates to be eligible. Here is the complete day-wise list of key...

Abbott Laboratories shares surged 12% after the healthcare company reported strong second-quarter sales, raised its full-year earnings outl...

Abbott Laboratories is in talks to buy Exact Sciences, a company known for its Cologuard cancer test. Reports say the possible deal is in a...

August 3 witnessed a remarkable surge in the BSE MidCap segment as several stocks hit new 52-week highs, displaying strong bullish momentum...

Shares of Abbott India Ltd. traded 0.63 per cent up in trade at 10:50AM on Tuesday .

The third name, which we have liked for a long time, and had once recommended at Rs 40 level, is Caplin Point Laboratories.

Looking at the numbers, which the management was talking about, the stock still does not look very expensive, says Irani.

'On the whole, a whole of pharma stocks, quite a few of them including some of the bigger names, according to me, are relatively expensive'

The CCI observed that "there is horizontal overlap" between the pharmaceutical products of Mylan and Abbott in India with respect to certai...

Shares of Glenmark Pharmaceuticals saw profit booking after the company announced that it has lost appeal to invalidate Abbott's patent for...

Drug firm Abbott India on Tuesday said its net profit rose by 7.6 per cent to Rs 23.90 crore for the quarter ended August 31.

Piramal Healthcare on Saturday said it has completed the Rs 600-crore deal to sell its diagnostics arm, PDSPL, to Super Religare Laboratori...

US-based pharmaceutical firm Abbott Laboratories announced completing the acquisition of the global drug business of Solvay SA, consequent ...

Domestic pharma company Lupin has reached an out-of-court settlement with US pharma major Abbott and Japan’s Astellas Pharma for the market...